Upcoming Live Programs

Coming Soon
HF21 / 21 episodes / 21 minutes: CHFS Perspective and Case-Based Approach on the 2021 CHFS/CCS HF Guidelines
September 9, 2021
Coming Soon
Top 3 Conundrums in HF: Worsening Heart Failure (7:00-8:00 pm ET)
September 21, 2021
Upcoming
CAN-R³ : Initiative canadienne pour la réduction du risque résiduel : Nouveautés dans la prise en charge de la dyslipidémie
September 23, 2021
7:00 p.m. HAE
Upcoming
HF21 series / 21 episodes / 21 minutes: Beyond Foundational Therapy: When to Reach in the Tool Box
September 27, 2021
Upcoming
HF21 series / 21 episodes / 21 minutes: Recommendations for Initiation of SGLT2i in Patients with HF and T2D
September 29, 2021
Upcoming
Underestimated: Assessing CV Risk in Female Patients and Residual Risk in Patients with CAD
September 30, 2021
7:00 p.m. EDT
Upcoming
HF21 series / 21 episodes / 21 minutes: Is it Time for Device Implementation yet?
October 4, 2021
Upcoming
L’ensemble d’ordonnances de la SCIC/SQIC pour les admissions liées à l’insuffisance cardiaque
October 4, 2021
7:30 p.m. EST
Upcoming
HF21 series / 21 episodes / 21 minutes: Is There a Right Way and a Wrong Way? Sequencing of Foundational Therapy in HFrEF
October 5, 2021
Upcoming
Is Colchicine the Third Pillar of Secondary Prevention of ASCVD?
October 5, 2021
8:00 p.m. EDT
Upcoming
La colchicine est-elle le troisième pilier de la prévention secondaire de la MCVA ?
October 27, 2021
7:00 p.m. EST
Upcoming
Is Colchicine the Third Pillar of Secondary Prevention of ASCVD?
October 28, 2021
7:00 p.m. EDT
Upcoming
2021 CHFS Heart Failure Admission Order Set Update
November 25, 2021
Upcoming
Is Colchicine the Third Pillar of Secondary Prevention of ASCVD?
November 30, 2021
7:00 p.m. EST
Looking for more? Visit our on-demand programs, available to watch at anytime.